To make the Human papillomavirus (HPV) tests affordable to the people, the All India Institute of Medical Sciences (AIIMS) has started a study of indigenous HPV tests for cervical cancer screening in India.
Mumbai (Maharashtra) [India], March 15: Cervical cancer, a potentially preventable and treatable disease, continues to be a significant global health concern. The primary virus associated with the development of cervical cancer is the human papillomavirus (HPV). While Human Papillomavirus (H
New Delhi [India], March 11: To create awareness and enable knowledge-sharing around cervical cancer screening, especially the benefits of early screening with liquid-based cytology and human papillomavirus (HPV) DNA testing, BD (Becton, Dickinson, and Company) conducted roadshows across sev
As Cervical cancer is second leading cause of deaths among women in India, the central government had announced plans to encourage vaccinations against the human papillomavirus (HPV) through its immunisation programme, is exploring options to cap prices so that the vaccines to treat cervical
The National Technical Advisory Group for Immunisation (NTAGI) has recommended introduction of The quadrivalent Human Papilloma Virus (qHPV) vaccine in the Universal Immunization Programme (UIP) with a one-time catch-up for 9-14 year-old adolescent girls followed with routine introduction
There have been some media reports speculating that the Union Government will launch a human papillomavirus (HPV) vaccination campaign in the second quarter of the year 2024 to target girls in the 9-14 years age group. Such reports are not true, said the Union Ministry of Health and Family W
New Delhi [India], October 31: Breast Cancer is the most common cancers in women in India. According to Breast Cancer India, one woman is diagnosed with the disease every four minutes and one woman dies of this disease in India every 8 minutes. India has a young population and hence, the num
According to a recent study, two liquid biopsy methods that identify people at high risk of developing cervical cancer again after chemoradiation by looking for the presence of the human papillomavirus (HPV) in their blood did a good job of doing so.
A new study reveals that two liquid biopsy techniques that detect the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence following chemoradiation.
At the annual meeting of the American Society for Radiation Oncol
Delhi Commission for Women (DCW) chief Swati Maliwal on Wednsday said that she issued notice to the Centre seeking the introduction of the HPV(Human Papillomavirus) vaccine in the Universal Immunization Programme for adolescent girls.
Salt Lake City (Utah) [US], July 19: Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced grants awarded by the Bill & Melinda Gates Foundation r
Chennai (Tamil Nadu) [India], July 3: Dr Vijayalakshmi Ramshankar, Department of Preventive Oncology (Research), Cancer Institute (WIA), today unveiled research titled "Impact of HPV molecular testing with partial genotyping as a feasibility study in cervical cancer community screening progr